Abstract | OBJECTIVE: STUDY DESIGN: The immunoreactivity for VEGF was studied in 130 invasive cervical carcinomas and in 22 patients with a carcinoma in situ of the cervix. The results were compared with the MVD. RESULTS: Staining for VEGF of less then 50% per slide occurred in 80% of the invasive carcinomas and in 82% of the in situ carcinomas. The median MVD was 261 vv/mm(2) (range: 11-1000) in the invasive group and 146 vv/mm(2) (range: 25-536) in the in situ group. Unlike the microvessel density there was no association between VEGF expression and survival. The MVD was higher in VEGF poorer (<50%) tumours (P=0.055). Beside tumour histology (P=0.012) there were no other significant relationships between the remaining histopathological findings and VEGF expression. CONCLUSION: Tissue VEGF expression has no prognostic value in contrast with the MVD in patients with invasive cervical cancer.
|
Authors | W Tjalma, J Weyler, B Weyn, E Van Marck, A Van Daele, P Van Dam, G Goovaerts, P Buytaert |
Journal | European journal of obstetrics, gynecology, and reproductive biology
(Eur J Obstet Gynecol Reprod Biol)
Vol. 92
Issue 2
Pg. 251-7
(Oct 2000)
ISSN: 0301-2115 [Print] Ireland |
PMID | 10996690
(Publication Type: Journal Article)
|
Chemical References |
- Endothelial Growth Factors
- Lymphokines
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
|
Topics |
- Adenocarcinoma
(blood supply, chemistry, pathology)
- Adult
- Aged
- Carcinoma, Adenosquamous
(blood supply, chemistry, pathology)
- Carcinoma, Squamous Cell
(blood supply, chemistry, pathology)
- Endothelial Growth Factors
(analysis)
- Female
- Humans
- Immunohistochemistry
- Lymphokines
(analysis)
- Microcirculation
(pathology)
- Middle Aged
- Prognosis
- Uterine Cervical Neoplasms
(blood supply, chemistry, pathology)
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
|